Jpmorgan Chase & CO Gsk PLC Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $13 Million - $14.7 Million	308,157 Added 127.67%	549,524 $23.9 Million
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $298,426 - $354,135	7,418 Added 3.17%	241,367 $10.5 Million
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $827,405 - $964,242	-21,281 Reduced 8.34%	233,949 $10.3 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $9.9 Million - $11 Million	255,230 New	255,230 $9.75 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.